Müller, Benjamin, et al. “Severe Cutaneous Toxicity in a 67-Year-Old Patient With Metastatic Urothelial Carcinoma Undergoing Therapy With Enfortumab Vedotin and Pembrolizumab”. European Journal of Case Reports in Internal Medicine, vol. 11, no. 12, Nov. 2024, https://doi.org/10.12890/2024_005003.